Cost effectiveness analysis of PEG-rhG-CSF versus rhG-CSF for primary prophylaxis of chemotherapy induced neutropenia in Chinese patients with non-Hodgkin lymphoma using real world data.

Saved in:
Bibliographic Details
Title: Cost effectiveness analysis of PEG-rhG-CSF versus rhG-CSF for primary prophylaxis of chemotherapy induced neutropenia in Chinese patients with non-Hodgkin lymphoma using real world data.
Authors: Zhu Y; Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.; Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China., Qu Y; Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China., Ding K; Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.; Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China., Chen R; Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China. chenrong1611@suda.edu.cn.; Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China. chenrong1611@suda.edu.cn.
Source: Discover oncology [Discov Oncol] 2026 Apr 07; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-026-04954-w